Funding & Support

Department of Pharmacology and Toxicology


  • DZHK “Alliance for the Identification and Validation of Tagets in Heart Failure” (2021-2025)
  • DZHK “Allianz für die Regeneration bei Herzinsuffizienz”, MD2 (2021-2025)
  • Fondation Leducq “Editing the Failing Heart” (2021-2025)
  • BMBF “Organersatz aus dem Labor“ – Individualisierte Herzmuskulatur für die Behandlung bei Herzinsuffizienz (IndiHEART) – Teilprojekt A (2021-2023)


  • DFG –SFB 1002 “Fibroblast-Cardiomyocyte Cross-Talk in Health and Disease: Focus on Cardiofibroblastopathies”; Projekt C04 (2020-2025)
  • DFG-SFB 1002 “In Vivo and In Vitro Disease Models, Projekt S01 (2020-2025)


  • DFG MBExC “Stem Cells and Organoids” (2019-2025)
  • DZHK – BioVAT-HF Early Clinical Trial “Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart-Failure” (2019-2024)


  • DFG IRTG 1816 “Phosphorylierungs- und redoxabhängige Signalmechanismen” (2017-2021)


  • “Physics-to-Medicine Initiative” of the Göttingen Campus, Lower Saxony Ministry for Science and Culture (MWK)


  • DFG SFB 937 (Collective behavior of soft and biological matter), A18 “Soft matter guided self-assembly of oscillating heart cells into functional macro-myocardium”


  • Leducq Transatlantic Network of Excellence “Programming the Heart to a Regenerative State” (Coordinators: R. Lee/M. Giacca)
  • NC3Rs – UK National Centre for the Replacement, Refinement and Reduction of Animals in Research; Phase 1 funding for CRACK IT Challenge 13: InPulse


  • DFG IRTG 1816 RP12 “Redox control of fibroblast-derived extracellular matrix and its implications for cardiomyocyte maturation and homeostasis”
  • CIRM/BMBF Early Translation III (FKZ: 13GW0007) “Heart Repair with Human Tissue Engineered Myocardium”


  • NIH-Progenitor Cell Biology Consortium (PCBC)
  • DFG SFB 1002 (Modulatory Units in Heart Failure), C04 “Control of the Myocardial Stroma by Fibroblasts” and S “Service project”


  • DZHK (German Center for Cardiovascular Research), Göttingen Partner Site GOE 3.2 HF “Regeneration from Heart Failure” – FKZ: 81Z3300132, GOE I.1 SCI “Experimental Stem Cell Bank” – FKZ: 81Z7300171, GOE I.2 SCI “Therapeutic Stem Cell Bank” – FKZ: 81Z7300172

Follow us